Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2019

View Archived Issues

Malaria vaccine has indirect protective effects

ActoBio Therapeutics announces IND approval for AG-017 for the treatment of celiac disease

Oral HRI activator EPB-53 improves glucose intolerance through FGF21

Experiments reveal the role of GDNF in intestinal epithelial barrier dysfunction in IBD

Study of RAC1 P29S mutation in melanoma points to target for reversing BRAF inhibitor resistance

Aerie initiates first-in-human study of AR-13503 sustained-release intravitreal Implant

First patient dosed in global phase II study of BT-11 in mild to moderate ulcerative colitis

Synlogic discontinues development of SYNB-1020 for the treatment of hyperammonemia

PI3K-alpha tested as a therapeutic target for prevention of heterotopic ossification

Novel mannosylated nanovaccines sensitize melanoma to immune checkpoint modulators

The other end of APP

Vertex Pharmaceuticals, Merck Patent disclose eIF-2-alpha kinase GCN2 inhibitors

More evidence links Schwann cells to pain

Sinovent discovers beta-lactamase inhibitors

Tau imagining agents patented by AC Immune, Life Molecular Imaging

Blastocyst-like embryonic structure grown from stem cells

ST Pharm presents new antivirals

New cyclin-dependent kinase 4/6 inhibitors identified at Beta Pharma

Phase III NEPTUNE study does not meet primary endpoint in patients with high TMB

Mersana Therapeutics initiates expansion portion of phase I trial of XMT-1536

First patient enrolled in observational study of children and adolescents with Dravet syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.